Stocktoria

Quantum Cyber N.V. QUCY

Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2021-11-04
Chart by TradingView
3/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024
Financials
Revenue$537,080$893,991
Gross profit$389,792$574,883
Operating income-$16.1M-$18.8M
Net income-$16.2M-$21.6M
Operating cash flow-$11.0M-$17.3M
Free cash flow-$11.0M-$17.4M
Total assets$5.3M$13.5M
Total liabilities$4.7M$7.5M
Shareholders' equity$641,600$6.0M
Ratios
Gross margin72.6%64.3%
Operating margin-3005.0%-2099.9%
Net margin-3018.3%-2416.0%
FCF margin-2044.5%-1950.2%
Return on assets-304.3%-160.0%
Return on equity-2526.6%-360.1%
Current ratio0.901.30
Revenue growth-39.9%

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: n/a

Not applicable (financials/insurer or missing inputs).

Sector peers

VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →

Source: SEC EDGAR filings · CIK 0001874252 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.